Polifeprosan 20, 3.85% Carmustine Slow-Release Wafer in Malignant Glioma: Evidence for Role in Era of Standard Adjuvant Temozolomide
Core Evidence - New Zealand
doi 10.2147/ce.s23244
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2012
Authors
Publisher
Informa UK Limited